Meta-Analyses Of Gene Methylation And Smoking Behavior In Non-Small Cell Lung Cancer Patients

Tao Huang,Xiaoying Chen,Qingxiao Hong,Zaichun Deng,Hongying Ma,Yanfei Xin,Yong Fang,Huadan Ye,Rujie Wang,Cheng Zhang,Meng Ye,Shiwei Duan
DOI: https://doi.org/10.1038/srep08897
IF: 4.6
2015-01-01
Scientific Reports
Abstract:Aberrant DNA methylation can be a potential genetic mechanism in non-small cell lung cancer (NSCLC). However, inconsistent findings existed among the recent association studies between cigarette smoking and gene methylation in lung cancer. The purpose of our meta-analysis was to evaluate the role of gene methylation in the smoking behavior of NSCLC patients. A total of 116 genes were obtained from 97 eligible publications in the current meta-analyses. Our results showed that 7 hypermethylated genes (including CDKN2A, RASSF1, MGMT, RARB, DAPK, WIF1 and FHIT) were significantly associated with the smoking behavior in NSCLC patients. The further population-based subgroup meta-analyses showed that the CDKN2A hypermethylation was significantly associated with cigarette smoking in Japanese, Chinese and Americans. In contrast, a significant association of RARB hypermethylation and smoking behavior was only detected in Chinese but not in Japanese. The genes with altered DNA methylation were likely to be potentially useful biomarkers in the early diagnosis of NSCLC.
What problem does this paper attempt to address?